396 related articles for article (PubMed ID: 27329728)
1. MiR-4638-5p inhibits castration resistance of prostate cancer through repressing Kidins220 expression and PI3K/AKT pathway activity.
Wang Y; Shao N; Mao X; Zhu M; Fan W; Shen Z; Xiao R; Wang C; Bao W; Xu X; Yang C; Dong J; Yu D; Wu Y; Zhu C; Wen L; Lu X; Lu YJ; Feng N
Oncotarget; 2016 Jul; 7(30):47444-47464. PubMed ID: 27329728
[TBL] [Abstract][Full Text] [Related]
2. MiR-361-5p acts as a tumor suppressor in prostate cancer by targeting signal transducer and activator of transcription-6(STAT6).
Liu D; Tao T; Xu B; Chen S; Liu C; Zhang L; Lu K; Huang Y; Jiang L; Zhang X; Huang X; Zhang L; Han C; Chen M
Biochem Biophys Res Commun; 2014 Feb; 445(1):151-6. PubMed ID: 24491557
[TBL] [Abstract][Full Text] [Related]
3. MiR-1247-5p is overexpressed in castration resistant prostate cancer and targets MYCBP2.
Scaravilli M; Porkka KP; Brofeldt A; Annala M; Tammela TL; Jenster GW; Nykter M; Visakorpi T
Prostate; 2015 Jun; 75(8):798-805. PubMed ID: 25731699
[TBL] [Abstract][Full Text] [Related]
4. Pirin: a potential novel therapeutic target for castration-resistant prostate cancer regulated by miR-455-5p.
Arai T; Kojima S; Yamada Y; Sugawara S; Kato M; Yamazaki K; Naya Y; Ichikawa T; Seki N
Mol Oncol; 2019 Feb; 13(2):322-337. PubMed ID: 30444038
[TBL] [Abstract][Full Text] [Related]
5. Functional roles and potential clinical application of miRNA-345-5p in prostate cancer.
Tinay I; Tan M; Gui B; Werner L; Kibel AS; Jia L
Prostate; 2018 Sep; 78(12):927-937. PubMed ID: 29748958
[TBL] [Abstract][Full Text] [Related]
6. Patient-derived Hormone-naive Prostate Cancer Xenograft Models Reveal Growth Factor Receptor Bound Protein 10 as an Androgen Receptor-repressed Gene Driving the Development of Castration-resistant Prostate Cancer.
Hao J; Ci X; Xue H; Wu R; Dong X; Choi SYC; He H; Wang Y; Zhang F; Qu S; Zhang F; Haegert AM; Gout PW; Zoubeidi A; Collins C; Gleave ME; Lin D; Wang Y
Eur Urol; 2018 Jun; 73(6):949-960. PubMed ID: 29544736
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-27a-5p regulation by promoter methylation and MYC signaling in prostate carcinogenesis.
Barros-Silva D; Costa-Pinheiro P; Duarte H; Sousa EJ; Evangelista AF; Graça I; Carneiro I; Martins AT; Oliveira J; Carvalho AL; Marques MM; Henrique R; Jerónimo C
Cell Death Dis; 2018 Feb; 9(2):167. PubMed ID: 29415999
[TBL] [Abstract][Full Text] [Related]
8. miR-188-5p inhibits tumour growth and metastasis in prostate cancer by repressing LAPTM4B expression.
Zhang H; Qi S; Zhang T; Wang A; Liu R; Guo J; Wang Y; Xu Y
Oncotarget; 2015 Mar; 6(8):6092-104. PubMed ID: 25714029
[TBL] [Abstract][Full Text] [Related]
9. Impact of novel miR-145-3p regulatory networks on survival in patients with castration-resistant prostate cancer.
Goto Y; Kurozumi A; Arai T; Nohata N; Kojima S; Okato A; Kato M; Yamazaki K; Ishida Y; Naya Y; Ichikawa T; Seki N
Br J Cancer; 2017 Jul; 117(3):409-420. PubMed ID: 28641312
[TBL] [Abstract][Full Text] [Related]
10. Identification of miR-30b-3p and miR-30d-5p as direct regulators of androgen receptor signaling in prostate cancer by complementary functional microRNA library screening.
Kumar B; Khaleghzadegan S; Mears B; Hatano K; Kudrolli TA; Chowdhury WH; Yeater DB; Ewing CM; Luo J; Isaacs WB; Marchionni L; Lupold SE
Oncotarget; 2016 Nov; 7(45):72593-72607. PubMed ID: 27683042
[TBL] [Abstract][Full Text] [Related]
11. Androgen-induced miR-27A acted as a tumor suppressor by targeting MAP2K4 and mediated prostate cancer progression.
Wan X; Huang W; Yang S; Zhang Y; Zhang P; Kong Z; Li T; Wu H; Jing F; Li Y
Int J Biochem Cell Biol; 2016 Oct; 79():249-260. PubMed ID: 27594411
[TBL] [Abstract][Full Text] [Related]
12. Screening key microRNAs for castration-resistant prostate cancer based on miRNA/mRNA functional synergistic network.
Zhu J; Wang S; Zhang W; Qiu J; Shan Y; Yang D; Shen B
Oncotarget; 2015 Dec; 6(41):43819-30. PubMed ID: 26540468
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of miR-582-5p regulates cellular proliferation of prostate cancer cells under androgen-deprived conditions.
Maeno A; Terada N; Uegaki M; Goto T; Okada Y; Kobayashi T; Kamba T; Ogawa O; Inoue T
Prostate; 2014 Dec; 74(16):1604-12. PubMed ID: 25176332
[TBL] [Abstract][Full Text] [Related]
14. Suppression of SPIN1-mediated PI3K-Akt pathway by miR-489 increases chemosensitivity in breast cancer.
Chen X; Wang YW; Xing AY; Xiang S; Shi DB; Liu L; Li YX; Gao P
J Pathol; 2016 Aug; 239(4):459-72. PubMed ID: 27171498
[TBL] [Abstract][Full Text] [Related]
15. GR silencing impedes the progression of castration-resistant prostate cancer through the JAG1/NOTCH2 pathway via up-regulation of microRNA-143-3p.
Zhang L; Jiang H; Zhang Y; Wang C; Xia X; Sun Y
Cancer Biomark; 2020; 28(4):483-497. PubMed ID: 32568179
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA expression signature of castration-resistant prostate cancer: the microRNA-221/222 cluster functions as a tumour suppressor and disease progression marker.
Goto Y; Kojima S; Nishikawa R; Kurozumi A; Kato M; Enokida H; Matsushita R; Yamazaki K; Ishida Y; Nakagawa M; Naya Y; Ichikawa T; Seki N
Br J Cancer; 2015 Sep; 113(7):1055-65. PubMed ID: 26325107
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-7 inhibits the stemness of prostate cancer stem-like cells and tumorigenesis by repressing KLF4/PI3K/Akt/p21 pathway.
Chang YL; Zhou PJ; Wei L; Li W; Ji Z; Fang YX; Gao WQ
Oncotarget; 2015 Sep; 6(27):24017-31. PubMed ID: 26172296
[TBL] [Abstract][Full Text] [Related]
18. The miR-139-5p regulates proliferation of supratentorial paediatric low-grade gliomas by targeting the PI3K/AKT/mTORC1 signalling.
Catanzaro G; Besharat ZM; Miele E; Chiacchiarini M; Po A; Carai A; Marras CE; Antonelli M; Badiali M; Raso A; Mascelli S; Schrimpf D; Stichel D; Tartaglia M; Capper D; von Deimling A; Giangaspero F; Mastronuzzi A; Locatelli F; Ferretti E
Neuropathol Appl Neurobiol; 2018 Dec; 44(7):687-706. PubMed ID: 29478280
[TBL] [Abstract][Full Text] [Related]
19. Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer.
Jalava SE; Urbanucci A; Latonen L; Waltering KK; Sahu B; Jänne OA; Seppälä J; Lähdesmäki H; Tammela TL; Visakorpi T
Oncogene; 2012 Oct; 31(41):4460-71. PubMed ID: 22266859
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-200a suppresses prostate cancer progression through BRD4/AR signaling pathway.
Guan H; You Z; Wang C; Fang F; Peng R; Mao L; Xu B; Chen M
Cancer Med; 2019 Apr; 8(4):1474-1485. PubMed ID: 30784214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]